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Summary: Troponin T concentration in serum is usually measured by the automated method developed by Boeh-
ringer Mannheim for the ES-series of analysers. These instruments need at least 140 μΐ of serum and 700 μΐ of
reagents for a single analysis, which takes 90 min. We describe an alternative procedure, using streptavidin-coated
microtitre plates, troponin T reagents of Boehringer Mannheim and an ELIS Α-reader to measure the concentration
of troponin T. The present assay needs only 30 μΐ of sample and 200 μΐ of reagents, and it takes 75 min; the
detection limit is 0.10 μg/l. We also assessed the microtitre plate method for sensitivity and precision and compared
the results with those measured by an ES-300 automatic analyser. Both methods have the same measurement range
for troponin T of 0.1 to 15 μg/l. For daily routine use of the microtitre plate method we recommend duplicate
determinations.
Introduction
Troponin T belongs to the troponin family of muscle
proteins (1,2). Troponins are located in the thin filament
of the myocyte. Troponin T has the highest relative mo-
lecular mass of 37000, other members of the family be-
ing troponin I (MT = 24 000) and troponin C (MT
= 20 000) (2). The function of troponin T is to bind
the other troponins to the tropomyosin filament of the
myocyte. Initially the cytosolic troponin T, but later also
the coniplexed troponin T are released from damaged
muscle cells into the circulation (3). This release de-
pends on the early reperfusion of the damaged area, and
it can be utilized to follow the progress of a myocardial
infarction (3,4). Troponin T is found in both myocardial
and in skeletal muscle. Differences in the amino acid
contents and structures of myocardial and skeletal tro-
ponin T (5) are sufficient to permit the preparation of
!) Enzymes
Isoenzyme MB of creatine kinase (EC 2.7.3.2)
Isoenzyme l of lactate dehydrogenase (EC 1.1.1.27)
highly specific antibodies against myocardial troponin T
(3, 5, 6). By using two selected monoclonal antibodies,
Katus and coworkers (7) developed a new and highly
specific enzyme-linked immunosorbent assay (ELISA)
for the measurement of serum cardiac troponin T, in
which skeletal troponin T in serum shows only minimal
cross reactivity. Many recent studies have shown that the
new troponin T method is very useful in the diagnosis of
acute myocardial infarction and for following the time
course of cardiac muscle perfusion in patients with un-
stable angina pectoris (4, 7, 8, 9).
In this article we describe a modification of the original
method for measuring troponin T in serum, using a stan-
dard microplate immunoassay reader and the commer-
cial reagents of Boehringer Mannheim (Mannheim, Ger-
many) for the ES-series of analysers. A very close
agreement was obtained between the results from the
ES-300 analyser and those from the microtitre plate
method. The microtitre plate method for troponin T can
therefore be used in place of the ES-300 analyser (10,
Π).
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Materials and Methods
Samples
For the present study, surplus serum from patients in the cardiac
care unit of the Kuopio University Hospital, taken for ordinary
serum enzyme assays, was used and stored at -70°C (10, 11)
until analysed for serum troponin T concentration. Venous blood
samples for enzyme determinations were collected with minimal
stasis and centrifuged within 60 min to obtain serum for analyses.
Haemolysed samples were replaced with new samples. For measur-
ing the variations within and between series, two serum pools were
made and divided into 1.0 ml portions and stored at -70 °C until
analysed. To evaluate the present method, patients with acute myo-
cardial infarction, with typical clinical signs, ECG-patterns and se-
rum enzyme1) activities (12) were monitored by the serial measure-
ment of serum troponin T concentration.
Methods and reagents
We measured serum troponin T with an ES-300 analyser using the
reagent kit of the ELISA Troponin-T Test of Boehringer Mannheim
(Cat. No. 1289055) for the ES-series of analysers (10, 11). The
reagents of the kit were used as recommended by the manufacturer.
The basic method uses 140 μΐ of serum (standard or control) and
700 μΐ of the mixture of two antibodies, the first complexed with
biotin and the second with peroxidase. After incubation of the mix-
ture for 60 min at 25 °C, the tubes were washed, substrate was
added (di-ammonium 2,2'-azino-bis[3-ethylbenzothiazoline-6-
sulphonate] and H2O2), and the tubes were incubated for 30 min
at 25 °C for colour formation. The colour intensity was then mea-
sured at 405 nm (tab. 1) and the troponin T concentration obtained
from the standard curve as calculated by the instrument.
Unmodified reagents produced by Boehringer Mannheim were
used for the determination of serum troponin T concentration as a
microtitre plate immunoassay method. Instead of the original tubes,
the reaction was performed in the 250 μΐ wells of a microtitre plate
after coating the wells with streptavidin. The wells of the microtitre
plate were coated for 24 h with streptavidin from Boehringer
Mannheim (14 U/mg) at a concentration of 10 mg/1 in 10 mmol/1
phosphate buffer, pH 7.2 containing 150 mmol/1 NaCl at + 4 °C.
The binding capacity of streptavidin for biotin on the walls of the
wells was at least 2 ng of biotin per well, which was found to be
sufficient. Commercial microtitre plates coated with streptavidin
(Boehringer Mannheim and Labsystems Oy, Helsinki, Finland)
could also be used. Coated microtitre plates were stored at + 4 °C
until used. Otherwise, the method was similar to that used with the
ES-300 analyser, with minor modifications of the ratios of sample
and reagent volumes (tab. 1). Sera, standards and controls were
dispensed into the wells of the plate with a manual pipette (Proline
5-50, Biohit Oy, Helsinki, Finland). The tip of the pipette was
changed after each operation. The mixture of antibodies to troponin
T was then added with a multitip automated pipette (Proline
Electronic 250, Biohit Oy). The plate was incubated for 60 min at
25 °C in a Wellwarm l shaker (Denley Instruments Ltd, Bill-
ingshurst, England) then washed twice with the washing solution
using a Multiwash instrument (Labsystems Oy, Helsinki, Finland).
The substrates (di-ammonium 2,2'-azino-bis[3-ethylbenzothiazo-
line-6-sulphonate] and H2O2) were then added and the microplate
was incubated on a Multiscan MCC/340 reader (Labsystems Oy)
for 15 min, after which the concentration of the colour in the wells
was read at 405 nm. The concentrations of troponin T were then
obtained from a standard curve made with the Multiscan reader.
The standard curve for troponin T was constructed by using the
following kit standards: 0.0, 0.9, 2.4, 5.2, 10.7 and 14.5 μβ/1. The
controls purchased with the kit were low (0.19 ± 0 06 ug/1) and
high (5.45 ± 0.82 μβ/1). The fitting of the standard curve was
studied by different modes of the Multiscan reader and also by
using a microcomputer.
For comparison of the clinical usefulness of the microtitre plate
troponin Τ method, the activity of serum creatine kinase1), its iso-
enzyme MB, the activity of lactate dehydrogenase and its isoen-
zyme 1 as well as the mass concentration of creatine kinase-MB
were measured. The activity of creatine kinase in serum was mea-
sured using a commercial assay by Boehringer Mannheim accord-
ing to the ECCLS recommendation (13) and Hitachi 717 Analyser
(Tokyo, Japan). The activity of serum creatine kinase-MB was
measured with the Boehringer Mannheirn kit which incorporates
an antibody for inhibition of the M-subunit; the value obtained for
the creatine kinase-B subunit was then doubled. The mass concen-
tration of creatine kinase-MB in serum was measured with a com-
mercial IMx® creatine kinase-MB assay (Abbott Laboratories, Ab-
bott Park, Chicago, 111., USA); the method uses a monoclonal anti-
creatine kinase-MB antibody bound to latex microparticles; the se-
cond antibody is a polyclonal anti-creatine kinase-MM antibody
coupled with alkaline phosphatase (14). After inhibition of the M-
containing isoenzymes with urea and qumidine at pH 10, lactate
dehydrogenase and its isoenzyme lactate dehydrogenase-1 were
measured using the lactate dehydrogenase-method of Boehringer
Mannheim and a Hitachi 717 analyser in accordance with the Scan-
dinavian Recommendation (15).
Statistics
The coefficients of variation and the correlation coefficients be-
tween the different methods were calculated using the StatView
4.0 software package (Abacus Concepts Inc., Berkeley, U. S. A.).
The results are expressed as the mean values with corresponding
standard deviations. The curve fittings by a microcomputer were
performed using SPSS/PC+ Statistical Data Analysis package
(SPSS Inc., Chicago, USA). v *_
Results and Discussion
Evaluation of the microtitre plate ELISA
method for the determination of troponin T in
serum
The purpose of the present investigation was to study
the possibility of adapting the commercial troponin Τ
test of Boehringer Mannheim to a standard microtitre
plate ELISA method using the reagents of the manufac-
turer as supplied for the ES-series of analysers. Each
step of the method was tested, and the results of serum
analyses were compared with those obtained with an
ES-300 analyser. In table 1 both procedures are pre-
sented.
The linearity of the Multiscan ELISA-reader was studied
by using 10 mmol/1 K-dichromate solution. It was found
that the instrument was linear at 405 nm up to an absor-
bance value of 2.400. Using solutions of K-dichromate
with absorbance values of 0.387 or 1.561, we pipetted
30 μΐ of the colour red solution with a single-tip manual
pipette (Proline 5-50) and 200 μΐ of H2O with a multitip
automated pipette (Proline Electronic 250) into the 250
μΐ wells of microtitre plates (from Labsystems). The co-
efficients of variation were 0.96 and 0.74%, respec-
tively.
The optimal streptavidin coating of the microtitre plate
wells was checked by using the highest troponin T stan-
dard and steptavidin-c ated plates from Labsystems (the
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Tab. l Protocols for the determinations of serum troponin T with
the microplate immunoassay and with an ES-300 analyser. ABTS®
= diammonium 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulpho-
nate).










Microtitre wells or tubes coated with streptavidin. The plates or
tubes were incubated for 60 min at 25 °C with continuous mixing.
Washing the samples and extra reagents one/two times with wash-
ing solution.
Microplate ES-300
Addition of reagents ABTS®
and H2O2
Volume






Measurement of the colour directly from the microtitre plate wells
or after transferring the coloured liquid to the cuvettes (ES-300)
at 405 nm.
Calculation of the results from the standard curves made by the in-
struments.
binding capacity was stated to be at least 2 ng biotin per
well). By varying the sample size (from 10 to 50 μΐ) it
was found that 30 μΐ or less resulted in similar values to
those obtained with an ES-300 analyser, but with sample
volumes of 40 μΐ and 50 μΐ the results were too low
(-12 and —32%, respectively). We also coated the wells
of a microtitre plate with different concentrations of
streptavidin (Boehringer Mannheim) and found that a
250 μΐ well should bind at least 2 ng of biotin, based on
the analysis of 30 μΐ of the highest troponin Τ standard
(the streptavidin tubes for the ES-series of analysers
have a binding capacity of approximately 14 ng of biotin
per tube).
Using an incubation temperature of 25 °C, it was shown
that the incubation times can be the same as in the origi-
nal method. However, the reaction time for substrate-
chromogen solution could be shortened from 30 min to
15 min in the microtitre plate technique (tab. 1). It was
also found that the incubation and the wash steps in the
microtitre plate method should be performed mechani-
cally rather than manually, in order to obtain constant
results. After checking the conditions, the standard curve
of the microtitre plate method was curvilinear (fig. 1)
as is the standard curve of the ES-300 analyser. The
measurement range was the same for both methods (0.1
'to 15 μg/l). The point-to-point calculation mode and the
second degree regression mode gave the best results
with the present method.
The difference between duplicate analyses were studied
over the whole measuring range by using human serum
samples. Figure 2 shows clearly that the percentage dif-
ferences increase at lower and higher troponin T concen-
trations. The situation was somewhat better when greater
amounts of streptavidin were used for coating the micro-
plate wells (data not shown). At concentrations below
the lowest standard (0.9 μg/l), the relative differences
were so high that duplicate analyses are recommended
for routine laboratory practice. In contrast, with an ES-
300 analyser, single determinations seem to fulfil the
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Fig. 2 Percentage differences between duplicate analyses for se-
rum troponin Τ measured by the microplate immunoassay method.
Eur J Clin Chem Clin Biochem 1995; 33 (No 1)
62 Penttil et al.: Microplate ELISA method for serum troponin T
Tab. 2 The within and between series variation of the troponin
T microplate method, using low and medium serum pools, and
controls from the manufacturer. The assayed values for the tro-
ponin T control sera were: low 0.19 ± 0.06 μ§/1 and high 5.2
± 0.82 Mg/l.
Coefficient of variation





















of troponin Τ method between series
Sample level Serum pool Control serum















criteria of acceptance even in the lower concentration
range (11).
Variations within and between series were studied by
using frozen serum pools and control samples (tab. 2).
At the troponin Τ concentrations of 0.2 and 2.2 μg/l in
serum pools or 0.2 and 4.5 μg/l in control samples, the
within series variations were between 1.52 and 2.44%.
The variations between series were higher and ranged
from 7.67 to 12.9% (tab. 2). It is possible that small
variations in the streptavidin binding capacity can
increase the coefficient of variation at the lower range,
or that the streptavidin binding capacity of the wells
should be greater.
The highest standard concentration in the kits is 14.5
μ§/1. In daily laboratory practice, several values are
higher than this, suggesting that the sample should be
diluted. The only obvious problem of standardisation
is the absence of a standard concentration near the
critical value of the measurement (between 0 and 0.9
μg/l). Such a standard would help to increase the
accuracy of the measurement of low serum troponin
Τ values.
A very close agreement was found between the meth-
ods when the values from the microtitre plate tech-
nique were compared with those obtained with an ES-
300 analyser (fig. 3). The mean values for 42 human
sera did not significantly differ for the two methods
(r = 0.99).
Detection limit, reference values and
discrimination limit of the microtitre plate
assay
The detection limit for troponin T in serum with the
present microtitre plate method was about 0.10 μg/l
when defined as the mean of 14 non-specific binding
values + 3 SD. In the sera of 63 healthy laboratory per-
sonnel, more than 95% of all troponin Τ values were
below 0.10 μ§/1, the highest value being 0.19 μg/l. By
doubling the value of 0.10 μg/l it can be stated that tro-
ponin Τ values in serum exceeding 0.20 μg/l should be
regarded as abnormal. This limit corresponds well with
those presented earlier (4, 10, 11, 16).
20
5 10 IS
Troponin T (ES-300 analyser)
Fig. 3 The comparison of the results for serum troponin Τ mea-
sured with the microplate immunoassay method and with an ES-
300 analyser, y = -0.059 + 0.988x (x = ES-300, y = microplate
method). Ν = 42, r = 0.99.
1000
100 ISO
Time after onset of symptoms [h)
zoo
Fig. 4 Aetypical time-curve of serum troponin Τ (Β) compared
with the catalytic activity concentrations of creatine kinase-MB (o)
and lactate dehydrogenase isoenzyme 1 (a) and the mass concen-
tration of creatine kinase-MB (·) in the serum of a patient with
acute myocardial infarction. » »
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In figure 4, typical changes of serum troponin T and
enzyme values in a patient with acute myocardial infarc-
tion with early reperfiision are presented. This clinical
result obtained with our modified method corresponds
well to previous observations made with automated as-
says for troponin T in serum (3, 4, 7, 11, 16).
Conclusion
A comparison of the values obtained with the microtitre
plate immunoassay method with those from an ES-300
analyser shows that the microtitre plate method can be
dised for the measurement of serum troponin T concen-
tration. The day-to-day variation still has to be reduced
and we are currently working on this problem. From a
clinical point of view the present method fulfils the
needs of daily clinical laboratory practice for the diagno-
sis of acute myocardial infarction, thus confirming the
usefulness of the troponin T assay.
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